Brief: United Laboratories International Gets China Approval For UBT37034 Clinical Trial
30/09/2025 11:26
Sept 30 (Reuters) - United Laboratories International Holdings Ltd 3933.HK: GETS CHINA APPROVAL FOR UBT37034 CLINICAL TRIAL UBT37034 IND APPLICATION APPROVED BY U.S. FDA Further company coverage: 3933.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million